These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19549514

  • 1. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):134-40. PubMed ID: 19549514
    [Abstract] [Full Text] [Related]

  • 2. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z, Skuza G.
    Pol J Pharmacol; 2001 Aug 15; 53(6):571-6. PubMed ID: 11985330
    [Abstract] [Full Text] [Related]

  • 3. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
    Rogóz Z, Skuza G, Kłlodzińska A.
    Pol J Pharmacol; 2004 Aug 15; 56(5):519-26. PubMed ID: 15591639
    [Abstract] [Full Text] [Related]

  • 4. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
    Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B.
    Biol Psychiatry; 2007 Apr 15; 61(8):990-5. PubMed ID: 17141743
    [Abstract] [Full Text] [Related]

  • 5. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
    Breuer ME, van Gaalen MM, Wernet W, Claessens SE, Oosting RS, Behl B, Korte SM, Schoemaker H, Gross G, Olivier B, Groenink L.
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan 15; 379(1):101-6. PubMed ID: 18668225
    [Abstract] [Full Text] [Related]

  • 6. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J, Dziedzicka-Wasylewska M, Rogoz R, Rogóz Z.
    Eur J Pharmacol; 1998 Jun 12; 351(1):31-7. PubMed ID: 9698202
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH.
    Psychopharmacology (Berl); 2009 Apr 12; 203(2):317-27. PubMed ID: 18807248
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L, Carey RJ, Carrera MP.
    Pharmacol Biochem Behav; 2007 Mar 12; 86(3):441-8. PubMed ID: 17291574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.
    Schulte-Herbrüggen O, Vogt MA, Hörtnagl H, Gass P, Hellweg R.
    Eur J Pharmacol; 2012 Feb 29; 677(1-3):77-86. PubMed ID: 22206815
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
    Kitagawa K, Kitamura Y, Miyazaki T, Miyaoka J, Kawasaki H, Asanuma M, Sendo T, Gomita Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul 29; 380(1):59-66. PubMed ID: 19274453
    [Abstract] [Full Text] [Related]

  • 15. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors.
    Fenu S, Espa E, Pisanu A, Di Chiara G.
    Eur J Pharmacol; 2016 Oct 05; 788():183-191. PubMed ID: 27343381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.
    Takahashi K, Nakagawasai O, Nemoto W, Nakajima T, Arai Y, Hisamitsu T, Tan-No K.
    Psychopharmacology (Berl); 2016 Apr 05; 233(7):1311-22. PubMed ID: 26856855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Some behavioural effects of antidepressant drugs are time-dependent.
    Dziedzicka-Wasylewska M, Rogóz Z, Margas W, Dlaboga D, Góralska M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb 05; 25(2):373-93. PubMed ID: 11294483
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.